Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:C07D

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.20230034917ION CHANNEL MODULATORS
US 02.02.2023
Int.Class C07D 487/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
487Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
Appl.No 17780042 Applicant Praxis Precision Medicines, Inc. Inventor Kiran REDDY

The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.

2.102022119036ORGANISCHE ELEKTROLUMINESZIERENDE VERBINDUNG, MEHRERE WIRTSMATERIALIEN UND DIESE UMFASSENDE ORGANISCHE ELEKTROLUMINESZIERENDE VORRICHTUNG
DE 02.02.2023
Int.Class C07D 421/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
421Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
02containing two hetero rings
04directly linked by a ring-member-to-ring- member bond
Appl.No 102022119036 Applicant Rohm And Haas Electronic Materials Korea Ltd. Inventor Jun Ji-Song

Die vorliegende Offenbarung betrifft eine organische elektrolumineszierende Verbindung, ein organisches elektrolumineszierendes Material und eine dieses umfassende organische elektrolumineszierende Vorrichtung, mehrere Wirtsmaterialien, die mindestens ein erstes Wirtsmaterial und mindestens ein zweites Wirtsmaterial umfassen, und eine organische elektrolumineszierende Vorrichtung, die diese umfasst. Durch Einbeziehung der Verbindung gemäß der vorliegenden Offenbarung als einziges Wirtsmaterial oder als mehrere Wirtsmaterialien kann eine organische elektrolumineszierende Vorrichtung mit verbesserter Treiberspannung, Lichtausbeute und/oder Lebensdauer im Vergleich zu den herkömmlichen organischen elektrolumineszierenden Vorrichtungen hergestellt werden.

3.WO/2023/006019POLYSUBSTITUTED BENZENE PD-L1 INHIBITOR, COMPOSITION AND USE THEREOF
WO 02.02.2023
Int.Class C07D 471/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
Appl.No PCT/CN2022/108538 Applicant HANGZHOU HEALZEN THERAPEUTICS CO., LTD. Inventor WU, Yizhe
Disclosed in the present invention are a polysubstituted benzene PD-L1 inhibitor, a composition and the use thereof. The compound has a structure as represented by general formula (I). The inventor of the present invention confirmed by means of an experiment that the compound of the present invention exhibits a strong PD-1/PD-L1 blocking activity and a significant PD-L1 occupancy activity, and can reverse a PD-L1-inhibited T cell function. Moreover, the compound of the present invention can be orally absorbed, has a good pharmacokinetic property, and has a good anti-tumor inhibitory activity in vivo. Thus, the compound of the present invention can be used alone or in combination with other drugs in the treatment of diseases, disorders or conditions which would benefit from the inhibition of PD1 or PD-L1 activity, including infectious diseases, immune diseases, inflammatory diseases and cancers.
4.WO/2023/009754PROTEIN-ANTIVIRAL COMPOUND CONJUGATES
WO 02.02.2023
Int.Class A61K 47/68
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
51the non-active ingredient being a modifying agent
68the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Appl.No PCT/US2022/038723 Applicant REGENERON PHARMACEUTICALS, INC. Inventor NITTOLI, Thomas
Provided herein are compounds, compositions, and methods for the treatment of diseases and disorders associated with influenza, including VX-787 and derivatives thereof, and protein (e.g., antibody) drug conjugates thereof.
5.WO/2023/009709PYRAZOLO PIPERAZINES AS JAK2 INHIBITORS
WO 02.02.2023
Int.Class C07D 487/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
487Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
Appl.No PCT/US2022/038657 Applicant AJAX THERAPEUTICS, INC. Inventor MASSE, Craig E.
The present disclosure provides pyrazolo piperazine compounds and compositions thereof useful for inhibiting JAK2.
6.WO/2023/006634METHOD FOR CONTROLLING DIAMIDE RESISTANT PESTS & COMPOUNDS THEREFOR
WO 02.02.2023
Int.Class A01N 43/56
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
43Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
48having rings with two nitrogen atoms as the only ring hetero atoms
561,2-Diazoles; Hydrogenated 1,2-diazoles
Appl.No PCT/EP2022/070720 Applicant SYNGENTA CROP PROTECTION AG Inventor STOLLER, André
A method for combating and controlling diamide-resistant insects to (i) reduce damage on a plant, which comprises applying to the insect, to a locus of the insect, or to a plant susceptible to attack by the insect an, effective amount of a compound of formula (I); or (ii) protect plant propagation material, which comprises treating the propagation material or the site, where the propagation material is planted, with an effective amount of a compound of formula (I); wherein the compound of formula I is wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.
7.WO/2023/007429PREPARATION OF PHENYL SULFILIMINES OR SULFOXIMINES CONTAINING THIAZOLYL-PIPERIDINYL COMPOUNDS AND INTERMEDIATES THEREOF
WO 02.02.2023
Int.Class C07D 261/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
261Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
02not condensed with other rings
04having one double bond between ring members or between a ring member and a non-ring member
Appl.No PCT/IB2022/057001 Applicant PI INDUSTRIES LTD. Inventor MADURKAR, Sanjay Maruti
The present invention discloses a process for the preparation of phenyl sulfilimines or sulfoximines containing thiazolyl-piperidinyl compounds of formula (I) wherein, R1, R2, Ra, Q, n and m are as defined in the description, and intermediates for preparing the compound of formula (I) or salts thereof.
8.WO/2023/007009PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS
WO 02.02.2023
Int.Class A61K 31/519
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
Appl.No PCT/EP2022/071464 Applicant ACTELION PHARMACEUTICALS LTD Inventor BAUMAN, David
The disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof. Pharmaceutical compositions comprising compounds of formula (I), as well as methods of their use and preparation, are also described.
9.WO/2023/007144ELECTROCHEMICAL TRANSFORMATIONS
WO 02.02.2023
Int.Class C25B 3/05
CCHEMISTRY; METALLURGY
25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON- METALS; APPARATUS THEREFOR
3Electrolytic production of organic compounds
01Products
05Heterocyclic compounds
Appl.No PCT/GB2022/051952 Applicant LOUGHBOROUGH UNIVERSITY Inventor BUCKLEY, Benjamin Roger
A process for synthesising a defined compound, such as solketal, wherein the process comprises subjecting a solution comprising another defined compound, such as glycerol, to a potential difference. A compound and a composition obtainable by the process, and a product comprising the compound or the composition.
10.WO/2023/008989HETEROGENEOUS SOLID CATALYST FILM FOR 2-AMINO-4H-CHROMENE SYNTHESIS
WO 02.02.2023
Int.Class B01J 21/06
BPERFORMING OPERATIONS; TRANSPORTING
01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
21Catalysts comprising the elements, oxides or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium or hafnium
06Silicon, titanium, zirconium or hafnium; Oxides or hydroxides thereof
Appl.No PCT/MA2021/000024 Applicant UNIVERSITÉ IBN TOFAIL Inventor EL AADAD, Halima
The present invention relates to a heterogeneous solid catalyst in the form of a film comprising: polystyrene, trimethyl phosphate and titanium dioxide, and also to the use thereof for 2-amino-4H-chromene synthesis. The catalyst film provided by the invention is used to solve the problem of high cost and low yields and the short lifetime of existing catalysts, and to efficiently catalyse 2-amino-4H-chromene synthesis at an ambient temperature while recovering end products of high purity with a yield which reaches 99%.